These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24287905)

  • 1. An exploratory evaluation of tyrosine hydroxylase inhibition in planaria as a model for parkinsonism.
    Prokai D; Nguyen T; Kamrowski K; Chandra A; Talamantes T; Baxter LR; Prokai L
    Int J Mol Sci; 2013 Nov; 14(12):23289-96. PubMed ID: 24287905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 3-iodo-L-tyrosine, a tyrosine hydroxylase inhibitor, on eye pigmentation and biogenic amines in the planarian, Dugesia dorotocephala.
    Ness DK; Foley GL; Villar D; Hansen LG
    Fundam Appl Toxicol; 1996 Apr; 30(2):153-61. PubMed ID: 8812261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess amounts of 3-iodo-l-tyrosine induce Parkinson-like features in experimental approaches of Parkinsonism.
    Fernández-Espejo E; Bis-Humbert C
    Neurotoxicology; 2018 Jul; 67():178-189. PubMed ID: 29885340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia.
    Kawahata I; Fukunaga K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines.
    Scholz J; Toska K; Luborzewski A; Maass A; Schünemann V; Haavik J; Moser A
    FEBS J; 2008 May; 275(9):2109-21. PubMed ID: 18355318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR.
    Hurley MJ; Mash DC; Jenner P
    Eur J Neurosci; 2003 Nov; 18(9):2668-72. PubMed ID: 14622169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
    Wang X; Yang HA; Wang XN; Du YF
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
    Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
    Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and Neuro-restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson's Disease.
    Cronin A; Grealy M
    Neuroscience; 2017 Dec; 367():34-46. PubMed ID: 29079063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.
    Shehadeh J; Double KL; Murphy KE; Bobrovskaya L; Reyes S; Dunkley PR; Halliday GM; Dickson PW
    Neurobiol Dis; 2019 Oct; 130():104524. PubMed ID: 31276794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parkinson's disease].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1801-14. PubMed ID: 6152497
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of tyrosine hydroxylase in Parkinson's disease.
    Zhu Y; Zhang J; Zeng Y
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):350-8. PubMed ID: 22483316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of tyrosine hydroxylase in management of Parkinson's disease.
    Feve AP
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):450-5. PubMed ID: 22583428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an enzyme-linked immunosorbent assay (ELISA) to measure the level of tyrosine hydroxylase protein in brain tissue from Parkinson's disease models.
    Fauss D; Motter R; Dofiles L; Rodrigues MA; You M; Diep L; Yang Y; Seto P; Tanaka K; Baker J; Bergeron M
    J Neurosci Methods; 2013 May; 215(2):245-57. PubMed ID: 23537934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.
    Korner G; Noain D; Ying M; Hole M; Flydal MI; Scherer T; Allegri G; Rassi A; Fingerhut R; Becu-Villalobos D; Pillai S; Wueest S; Konrad D; Lauber-Biason A; Baumann CR; Bindoff LA; Martinez A; Thöny B
    Brain; 2015 Oct; 138(Pt 10):2948-63. PubMed ID: 26276013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency.
    Salvatore MF; McInnis TR; Cantu MA; Apple DM; Pruett BS
    Mol Neurobiol; 2019 Apr; 56(4):2728-2740. PubMed ID: 30056575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological assessment of methamphetamine-induced behavioral hyperactivity mediated by dopaminergic transmission in planarian Dugesia japonica.
    Tashiro N; Nishimura K; Daido K; Oka T; Todo M; Toshikawa A; Tsushima J; Takata K; Ashihara E; Yoshimoto K; Agata K; Kitamura Y
    Biochem Biophys Res Commun; 2014 Jul; 449(4):412-8. PubMed ID: 24858686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
    Abbaoui A; Chatoui H; El Hiba O; Gamrani H
    Neurosci Lett; 2017 Nov; 660():103-108. PubMed ID: 28919537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.